Remove Blood Clot Remove Patient Care Remove Stroke
article thumbnail

University of Cincinnati Study Finds Severe Ischemic Strokes are Rare in Patient Population

DAIC

Photo/University of Cincinnati milla1cf Thu, 05/16/2024 - 15:31 May 16, 2024 — A new University of Cincinnati study provides more insight into how few patients have severe ischemic strokes compared to the total stroke patient population in the region.

article thumbnail

ZODIAC Clinical Trial Led by UT Health Science Center Professor Likely to Make Major Impact on Stroke Care

DAIC

Image courtesy of the UT Health Science Center milla1cf Thu, 02/15/2024 - 13:16 February 15, 2024 — Research findings in a clinical trial led by a professor at the University of Tennessee Health Science Center ’s College of Nursing are likely to dramatically change care and improve outcomes for patients suffering from acute stroke.

Stroke 105
article thumbnail

Osso VR Expands Cardiology Training through ACC Collaboration

DAIC

Left Atrial Appendage Occlusion (LAAO) procedures are done to reduce the risk of stroke in patients with atrial fibrillation by sealing off the left atrial appendage, preventing the formation of blood clots. and globally."

article thumbnail

Philips Launches New Azurion Neuro Biplane System at #ECR2024 to Speed Up and Improve Minimally Invasive Diagnosis and Treatment of Neurovascular Patients

DAIC

Designed to improve productivity and help care teams make the right decisions faster, treat more patients, and achieve better outcomes, the new interventional system features enhanced 2D and 3D imaging and X-ray detector positioning flexibility. The faster stroke is treated, the better the potential outcome.

article thumbnail

Avicenna.AI Secures FDA Clearance for Two Healthcare AI Solutions

DAIC

This is particularly relevant in the cancer patient population, where pulmonary embolism is a significant cause of mortality. The CINA-iPE algorithm identifies lung blood clots detected during routine CT scans for entirely different health conditions. For more information: www.avicenna.ai

Embolism 105
article thumbnail

2024’s Mid-Year Review: FDA-Approved Cardiorenal Metabolic Drugs and Devices 

Cardiometabolic Health Congress

Staying informed about these cutting-edge developments is critical for providing exceptional patient care. Join us as we examine the landmark approvals that are revolutionizing patient outcomes. The label includes a “black box” warning for CV risk due to blood clots.

article thumbnail

Volta Medical Enters into Joint Development Agreement with GE HealthCare to Support Electrophysiologists Treating Atrial Fibrillation

DAIC

Mohr-Durdez added, “To help enhance patient care in this field, Volta Medical aims to further integrate its AI solution with EP innovators to help increase compatibility and address the challenges clinicians face in analyzing cardiac electrical signals.” 1 Approximately 33 million patients worldwide are living with AFib.